WEAVER GREGORY L

Filings at 1 company/Chief financial officer · Altimmune, Inc.

5 of 8 shown

The 5 most recent of 8 visible filings, newest first.

  • Altimmune, Inc. Chief financial officer
    $16,200Open-market buy
    TradedNov 13, 2026FiledNov 13, 2026
  • Altimmune, Inc. Chief financial officer
    18,750 sharesOption exercise
    TradedNov 11, 2026FiledNov 13, 2026
  • Altimmune, Inc. Chief financial officer
    $10,947Administrative
    TradedNov 11, 2026FiledNov 13, 2026
  • Altimmune, Inc. Chief financial officer
    18,750 sharesOption exercise
    TradedNov 11, 2026FiledNov 13, 2026
  • Altimmune, Inc. Chief financial officer
    14,475 sharesOption exercise
    TradedOct 1, 2026FiledOct 5, 2026